Author:
Atallah Edmond,Aithal Guruprasad P.
Publisher
Springer International Publishing
Reference20 articles.
1. Aithal GP. Drug-induced liver injury. Medicine. 2015;43(10):590–3.
2. Björnsson E, Bergmann O, Björnsson H, Kvaran R, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419–25.
3. Wing K, Bhaskaran K, Pealing L, Root A, Smeeth L, van Staa TP, et al. Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study. J Antimicrob Chemother. 2017;72(9):2636–46.
4. Donaghy L, Barry FJ, Hunter JG, Stableforth W, Murray IA, Palmer J, et al. Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre. Eur J Gastroenterol Hepatol. 2013;25(10):1159–64.
5. Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512–21.